Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04028700 · ClinicalTrials.gov registry record · Phase 2
The Impact of Oxidative Stress on Erythrocyte Biology
A Phase 2 study, sponsored by University of North Carolina, Chapel Hill.
- Terminated
- Registry status
- Phase 2
- Development phase
- 8
- Enrollment target
NCT04028700 is a Phase 2 study that was terminated before completion, run by University of North Carolina, Chapel Hill. The registered enrollment target is 8 participants.
The verdict
NCT04028700, a Phase 2 study, was terminated before completion, sponsored by University of North Carolina, Chapel Hill.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 8 participants
- Enrollment target
Study Summary
This study will address if red blood cells transfused to a sickle cell patient from a donor with a glucose-6-phosphate-dehydrogenase (G6PD) enzyme deficiency have a different lifespan as measured by the percentage of red blood cells that survive post-transfusion compared to red blood cells transfused to a sickle cell patient from a donor without a G6PD enzyme deficiency.
Interventions
- BIOLOGICAL G6PD Deficient Red Blood Cell Transfusion
- BIOLOGICAL Non-G6PD deficient Red Blood Cell Transfusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2022-01-02 |
| Est. Completion | 2024-08-16 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04028700
The ClinicalTrials.gov registry entry for NCT04028700 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which G6PD Deficient Red Blood Cell Transfusion is the first listed.
NCT04028700 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04028700 about?
NCT04028700 is a clinical study titled "The Impact of Oxidative Stress on Erythrocyte Biology". This study will address if red blood cells transfused to a sickle cell patient from a donor with a glucose-6-phosphate-dehydrogenase (G6PD) enzyme deficiency have a different lifespan as measured by the percentage of red blood cells that survive post-transfusion compared to red blood cells transfuse...
What is the current status of trial NCT04028700?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 8 participants. The study started on 2022-01-02. Estimated completion is 2024-08-16.
What interventions are being tested in trial NCT04028700?
The interventions under investigation include: G6PD Deficient Red Blood Cell Transfusion (BIOLOGICAL), Non-G6PD deficient Red Blood Cell Transfusion (BIOLOGICAL).
Who is sponsoring clinical trial NCT04028700?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.